CDX2 - A Predictive Biomarker in Stage II Colon Cancer for Adjuvant Chemotherapy?

Journal Title: Colorectal Cancer: Open Access - Year 2017, Vol 3, Issue 1

Abstract

In the United States, colorectal cancer (CRC) is the third most common cancer among men and women. Estimated new cases were 134,490 in 2016, which was 8% of all new cancer cases, while 49,190 deaths were expected [1]. The Tumor- Node-Metastasis (TNM) system of the American Joint Committee on Cancer is the most commonly used system for staging CRC and serves as a predictor of five-year survival [2]. Approximately 28% of patients with colon cancer present with stage II colon cancer [3].

Authors and Affiliations

Huang K, Jennifer W

Keywords

Related Articles

CDX2 - A Predictive Biomarker in Stage II Colon Cancer for Adjuvant Chemotherapy?

In the United States, colorectal cancer (CRC) is the third most common cancer among men and women. Estimated new cases were 134,490 in 2016, which was 8% of all new cancer cases, while 49,190 deaths were expected [1]. Th...

Incidence and Clinical Characteristics of Colonic and Extra Colonic Lynch Syndrome Manifestations in Uruguayan Mismatch Repair Carriers

Background: Colon cancer is a frequent diagnosis worldwide affecting both men and women. Lynch syndrome in an autosomal dominant inheritable condition, accountable for 5 to 7% of colon cancer, as well as other malignanci...

Raising the Bar on Rectal Cancer: The National Accreditation Program for Rectal Cancer

Since the concept of total mesorectal excision (TME), fostered by Heald, for the surgical management of rectal cancer, a new standard for rectal cancer treatment has emerged. Advances in surgical technique, medical and r...

Updates on the Molecular Genetics of Colorectal Cancer

Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. Although definitive therapies for advanced disease are still lacking, rapid progress has been made in the last decade in understanding the molecul...

Successful Endoscopic Management of Colonic Cavernous Vascular Malformation: A Rare Cause of Hematochezia

Despite approaching 200 years since they were first documented to exist, cavernous vascular malformations of the gastrointestinal tract remain exceedingly rare. To date about 350 cases have been reported [1]. Unlike hema...

Download PDF file
  • EP ID EP311231
  • DOI 10.21767/2471-9943.100035
  • Views 109
  • Downloads 0

How To Cite

Huang K, Jennifer W (2017). CDX2 - A Predictive Biomarker in Stage II Colon Cancer for Adjuvant Chemotherapy?. Colorectal Cancer: Open Access, 3(1), 1-3. https://europub.co.uk/articles/-A-311231